Search Results - "Valerio, Heather"

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis by Hajarizadeh, Behzad, Cunningham, Evan B., Valerio, Heather, Martinello, Marianne, Law, Matthew, Janjua, Naveed Z., Midgard, Håvard, Dalgard, Olav, Dillon, John, Hickman, Matthew, Bruneau, Julie, Dore, Gregory J., Grebely, Jason

“…HCV reinfection following successful treatment can compromise treatment outcomes. This systematic review assessed the rate of HCV reinfection following…”
Get full text

The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study by Alavi, Maryam, Janjua, Naveed Z., Chong, Mei, Grebely, Jason, Aspinall, Esther J., Innes, Hamish, Valerio, Heather M., Hajarizadeh, Behzad, Hayes, Peter C., Krajden, Mel, Amin, Janaki, Law, Matthew G., George, Jacob, Goldberg, David J., Hutchinson, Sharon J., Dore, Gregory J.

“…[Display omitted] •Alcohol use disorder is a major contributor to HCV-related liver disease burden.•Alcohol use could reduce individual and population level…”
Get full text

Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications by Kwon, Jisoo A, Dore, Gregory J, Hajarizadeh, Behzad, Alavi, Maryam, Valerio, Heather, Grebely, Jason, Guy, Rebecca, Gray, Richard T

“…Australia was one of the first countries to introduce government-funded unrestricted access to direct-acting antiviral (DAA) therapy, with 88,790 treated since…”
Get full text

Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause‐specific outcomes by Innes, Hamish A., McDonald, Scott A., Dillon, John F., Allen, Sam, Hayes, Peter C., Goldberg, David, Mills, Peter R., Barclay, Stephen T., Wilks, David, Valerio, Heather, Fox, Ray, Bhattacharyya, Diptendu, Kennedy, Nicholas, Morris, Judith, Fraser, Andrew, Stanley, Adrian J., Bramley, Peter, Hutchinson, Sharon J.

“…Sustained viral response (SVR) is the optimal outcome of hepatitis C virus (HCV) therapy, yet more detailed data are required to confirm its clinical value…”
Get full text

Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia by Yousafzai, Mohammad T., Alavi, Maryam, Valerio, Heather, Hajarizadeh, Behzad, Grebely, Jason, Dore, Gregory J.

“…This study aimed to identify the factors associated with timely (within four weeks) HCV RNA testing and timely (within six months) DAA initiation following HCV…”
Get full text

Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population by Innes, Hamish, McDonald, Scott, Hayes, Peter, Dillon, John F, Allen, Sam, Goldberg, David, Mills, Peter R, Barclay, Stephen T, Wilks, David, Valerio, Heather, Fox, Ray, Bhattacharyya, Diptendu, Kennedy, Nicholas, Morris, Judith, Fraser, Andrew, Stanley, Adrian, Bramley, Peter, Hutchinson, Sharon J

“…Graphical abstract…”
Get full text

Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study by Conway, Anna, Read, Phillip, Gilliver, Rosie, McNaughton, Tony, Valerio, Heather, Cunningham, Evan B, Henderson, Charles, Hadlow, Brett, Molloy, Katrina, Doab, Anna, Tillakeratne, Shane, Pepolim, Lucy, Harrod, Mary Ellen, Dore, Gregory J, Grebely, Jason

“…New technologies and therapies allow the possibility of a single-visit test and treat model for hepatitis C virus (HCV), addressing some of the barriers to…”
Get full text

A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study by Conway, Anna, Valerio, Heather, Alavi, Maryam, Silk, David, Treloar, Carla, Hajarizadeh, Behzad, Marshall, Alison D, Martinello, Marianne, Milat, Andrew, Dunlop, Adrian, Murray, Carolyn, Prain, Bianca, Henderson, Charles, Amin, Janaki, Read, Phillip, Marks, Pip, Degenhardt, Louisa, Hayllar, Jeremy, Reid, David, Gorton, Carla, Lam, Thao, Christmass, Michael, Wade, Alexandra, Montebello, Mark, Dore, Gregory J, Grebely, Jason

“…This study evaluated HCV treatment initiation among people who inject drugs (PWID) following an intervention of campaign days involving peer connection,…”
Get full text

Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales by Shah, Syed Hassan Bin Usman, Alavi, Maryam, Hajarizadeh, Behzad, Matthews, Gail V., Martinello, Marianne, Danta, Mark, Amin, Janaki, Law, Matthew G., George, Jacob, Valerio, Heather, Dore, Gregory J.

“…Population-level trends and factors associated with HBV-related decompensated cirrhosis (DC), hepatocellular carcinoma (HCC), and liver-related mortality are…”
Get full text

Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia by Alavi, Maryam, Law, Matthew G., Valerio, Heather, Grebely, Jason, Amin, Janaki, Hajarizadeh, Behzad, Selvey, Christine, George, Jacob, Dore, Gregory J.

“…[Display omitted] •Prior to the introduction of DAA therapy, the disease burden of HCV was rising in New South Wales.•DAA scale-up has had a major…”
Get full text

Cascade of care among people with an HBV notification in New South Wales, Australia, including diagnosis, specialist assessment, and treatment uptake by Usman Shah, Syed Hassan Bin, Valerio, Heather, Hajarizadeh, Behzad, Alavi, Maryam, Matthews, Gail, Dore, Gregory

Get full text

FRI-169 - Cascade of care among people with an HBV notification in New South Wales, Australia, including diagnosis, specialist assessment, and treatment uptake by Usman Shah, Syed Hassan Bin, Valerio, Heather, Hajarizadeh, Behzad, Alavi, Maryam, Matthews, Gail, Dore, Gregory

Get full text

The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort‐study by Innes, Hamish, McAuley, Andrew, Alavi, Maryam, Valerio, Heather, Goldberg, David, Hutchinson, Sharon J.

“…In resource‐rich countries, chronic hepatitis C (CHC) infection is associated with a sizeable excess mortality risk. The extent to which this is due to (1) the…”
Get full text

Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis by Grebely, Jason, Tran, Lucy, Degenhardt, Louisa, Dowell-Day, Alexander, Santo, Thomas, Larney, Sarah, Hickman, Matthew, Vickerman, Peter, French, Clare, Butler, Kerryn, Gibbs, Daisy, Valerio, Heather, Read, Phillip, Dore, Gregory J, Hajarizadeh, Behzad

“…People who inject drugs (PWID) experience barriers to accessing testing and treatment for hepatitis C virus (HCV) infection. Opioid agonist therapy (OAT) may…”
Get full text

Creating an environment for equitable access to direct‐acting antiviral therapy for people who inject drugs with hepatitis C by Dore, Gregory J., Valerio, Heather, Grebely, Jason

Get full text

Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study by Valerio, Heather, Alavi, Maryam, Silk, David, Treloar, Carla, Martinello, Marianne, Milat, Andrew, Dunlop, Adrian, Holden, Jo, Henderson, Charles, Amin, Janaki, Read, Phillip, Marks, Philippa, Degenhardt, Louisa, Hayllar, Jeremy, Reid, David, Gorton, Carla, Lam, Thao, Dore, Gregory J, Grebely, Jason

“…Evaluating progress towards HCV elimination is critical. This study estimated prevalence of current HCV infection and HCV treatment uptake among people who…”
Get full text

Hepatitis C care cascade before and during the direct‐acting antiviral eras in New South Wales, Australia: A population‐based linkage study by Yousafzai, Mohammad T., Alavi, Maryam, Valerio, Heather, Hajarizadeh, Behzad, Grebely, Jason, Dore, Gregory J.

“…The hepatitis C virus (HCV) care cascade characterization is important for monitoring progress towards HCV elimination. This study evaluated HCV care cascade…”
Get full text

Incidence and risk factors of hepatitis C liver morbidity and mortality in the era of direct-acting antiviral therapies: a population-based linkage study by Alavi, Maryam, Valerio, Heather, Law, Matthew, Lockart, Ian, Danta, Mark, Grebely, Jason, Amin, Janaki, Hajarizadeh, Behzad, George, Jacob, Dore, Gregory

Get full text

High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia by Valerio, Heather, Alavi, Maryam, Law, Matthew, Tillakeratne, Shane, Amin, Janaki, Janjua, Naveed Z., Krajden, Mel, George, Jacob, Matthews, Gail V., Hajarizadeh, Behzad, Degenhardt, Louisa, Grebely, Jason, Dore, Gregory J.

“…High HCV treatment uptake among people at most risk of transmission is essential to achieve elimination. We aimed to characterise subpopulations of people with…”
Get full text

The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen by Innes, Hamish, Barclay, Stephen T., Hayes, Peter C., Fraser, Andrew, Dillon, John F., Stanley, Adrian, Bathgate, Andy, McDonald, Scott A., Goldberg, David, Valerio, Heather, Fox, Ray, Kennedy, Nick, Bramley, Pete, Hutchinson, Sharon J.

“…[Display omitted] •Crude risk of HCC higher for IFN-free recipients than IFN-containing recipients.•IFN-free and IFN-containing recipients differ with respect…”
Get full text